trending Market Intelligence /marketintelligence/en/news-insights/trending/10ST2HkgXKRjoKfnuU8ACw2 content esgSubNav
In This List

ContraVir implements 1-for-70 reverse stock split

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


ContraVir implements 1-for-70 reverse stock split

ContraVir Pharmaceuticals Inc. implemented a 1-for-70 reverse stock split of its common shares, effective May 31.

The Edison, N.J.-based biopharmaceutical company is undertaking the transaction to regain compliance with Nasdaq Capital Market's minimum bid price listing requirement.

The company's common shares will start trading on a split-adjusted basis on June 3 under the existing symbol CTRV.

ContraVir's board in March approved the reverse stock split, which was later endorsed by a majority of the company's shareholders May 2.